Capturing the host response by using genomic technologies such as transcriptional profiling provides a new paradigm for classifying and diagnosing infectious disease and for potentially distinguishing infection from other causes of serious respiratory illness. This strategy has been used to define a blood-based RNA signature as a classifier for pandemic H1N1 influenza infection that is distinct from bacterial pneumonia and other inflammatory causes of respiratory disease. To realize the full potential of this approach as a diagnostic test will require additional independent validation of the results and studies to examine the specificity of this signature for viral versus bacterial infection or co-infection. © 2012 BioMed Central Ltd.
CITATION STYLE
Ginsburg, G. S., & Woods, C. W. (2012, November 6). The host response to infection: advancing a novel diagnostic paradigm. Critical Care. https://doi.org/10.1186/cc11685
Mendeley helps you to discover research relevant for your work.